Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?

European Journal of Cancer

Volumn 35, Issue 3, 1999, Pages 406-409

  Tierney, J F ^a   Stewart, L A ^b   Parmar, M K B ^b  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b NONE

Author keywords

Cervix neoplasms; Drug therapy; Meta analysis; Randomised controlled trials; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RELIABILITY; STATISTICS; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0033106397     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00404-3     Document Type: Article

References (22)

1. Benedet J., Odicino F., Maisonneuve P., et al. Carcinoma of the cervix uteri. J. Epidemiol. Biost. 3:1998;5-34.
2. Eifel PJ, Berek JS, Thigpen JT. Gynecologic Tumors. In DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 5th edition. Philadelphia, Lippincott-Raven, 1997, 1427-1478.
3. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In Chalmers I, Altman DG, eds. Systematic Reviews. London, Br Med J, 1995, 17-36.
4. Chauvergne J., Lhomme C., Rohart J., et al. Chimiothérapie néoadjuvante des cancer du col utérin aux stades IIb e III. Résultats éloignés d'un essai randomisé pluricentrique portant sur 151 patients. Bull. Cancer (Paris). 80:1993;1069-1079.
5. Kumar L., Kaushal R., Nandy B., et al. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol. Oncol. 54:1994;301-315.
6. Leborgne F., Leborgne J.H., Doldán R., et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 37:(2):1997;343-350.
7. Sardi J.E., Giaroli A., Sananes C., et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in Stage Ib squamous carcinoma of the cervix. The final results. Gynecol. Oncol. 67:1997;61-69.
8. Souhami L., Gil R.A., Allan S.E., et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in Stage IIIB carcinoma of the cervix. J. Clin. Oncol. 9:(6):1991;970-977.
9. Sundfor K., Tropé C.G., Högberg T., et al. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma Stage 3B and 4A. Cancer. 77:1996;2371-2378.
10. Tattersall M.H.N., Ramirez C., Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy alone in patients with locally advanced cervical cancer. Int. J. Gynecol. Cancer. 2:1992;244-251.
11. Tattersall M.H.N., Lorvidhaya V., Vootiprux V., et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J. Clin. Oncol. 13:(2):1995;444-451.
12. Chiara S., Bruzzone M., Merlini L., et al. Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. Am. J. Clin. Oncol. 17:(4):1994;294-297.
13. Tobias J., Buxton E.J., Blackledge G., et al. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Cancer Chemother. Pharmacol. 26:(Suppl):1990;S59-S62.
14. Cárdenas J, Olguín A, Figueroa F, Peña J, Beccerra F, Huizar R. A randomized trial of chemotherapy (CT) followed by radiotherapy (RT) vs radiotherapy alone in Stage IIIb cervical carcinoma: preliminary results. Fourth International Congress on Anti-Cancer Chemotherapy 1993, 87.
15. Kumar L, Pokharel YH, Grover GK, Rath GK, Kochupillai V. Neoadjuvant chemotherapy (CT) followed by radiotherapy (RT) in locally advanced squamous cell cervical cancer (SCC): two randomized studies. Proc. ASCO 1997, 16, 364a, abstract 1295.
16. Sardi J, Sananes C, Giaroli A, Di Paola G. Neoadjuvant chemotherapy in squamous cervical carcinoma, Stage IIIb. Gynecol Oncol 1994, 52, 104, abstract 10.
17. Sardi J, Giaroli A, Sananes C, Soderini A, Bermudez A, Di Paola G. Neoadjuvant chemotherapy (Nch) in Stage IIB cervical carcinoma: results of a four arms randomized trial. Int. J. Gynecol. Cancer 1997, 7(Suppl 2), 3, abstract 009.
18. Symonds RP, Cowie V, Davidson SE, et al. The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer. Int J Gynecol Cancer 1997, 7(Suppl 2), 18, abstract 050.
19. Stewart LA. The role of overviews. In Williams CJ, ed. Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems. Chichester, John Wiley, 1992, 383-401.
20. Stewart L.A., Parmar M.K.B. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 341:1993;418-422.
21. Early Breast Cancer Trialists Collaborative Group. Treatment of Early Breast Cancer, Vol 1. Worldwide Evidence 1990. Oxford, Oxford University Press, 1990.
22. Shueng P-W., Hsu W-L., Jen Y-M., et al. Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;889-896.